Valuation (48%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 26.52 | N/A |
| PEG Ratio (TTM) | 0.27 | N/A |
| P/S Ratio (TTM) | N/A | N/A |
| P/B Ratio (TTM) | 1.39 | N/A |
| P/FCF Ratio (TTM) | N/A | N/A |
| Price to 5YR AVG Earnings Ratio | 67.27 | N/A |
| Price to 5YR AVG FCF Ratio | 18.47 | N/A |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 2.91% | N/A |
| ROE (TTM) | 5.42% | N/A |
| Net Profit Margin (TTM) | 14.44% | N/A |
| ROIC 5YR AVG | -82.33% | N/A |
Growth (53%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 36.45% | -19.99% | -18.69% |
| Revenue | 0.79% | 14.09% | 10.29% |
| Net Income | 36.55% | -28.89% | -23.83% |
| Cash Flow | 24.21% | 110.69% | 58.09% |
Health (88%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 28.10 | N/A |
| Quick Ratio (TTM) | 28.10 | N/A |
| D/E Ratio (TTM) | 0.17 | N/A |
| Interest Coverage (TTM) | 1.44 | N/A |
| Piotroski F-Score | 7 | N/A |
| Altman Z-Score | 7.14 | N/A |
| LTL to 5YR AVG FCF | 1.42 | N/A |
| Shares Outstanding Growth 5YR AVG | 2.86% | N/A |